CA Patent

CA2599649C — Drug formulations having controlled bioavailability

Assigned to Bayer Intellectual Property GmbH · Expires 2013-11-12 · 13y expired

What this patent protects

The present application relates to novel drug formulations of vardenafil which dissolve rapidly in the mouth and have controlled bioavailability, and to processes for their preparation.

USPTO Abstract

The present application relates to novel drug formulations of vardenafil which dissolve rapidly in the mouth and have controlled bioavailability, and to processes for their preparation.

Drugs covered by this patent

Patent Metadata

Patent number
CA2599649C
Jurisdiction
CA
Classification
—
Expires
2013-11-12
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Intellectual Property GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.